Wang Y, Wu ZL, Wang YG, Wang H, Jia XY. Early colorectal cancer screening–no time to lose. World J Gastroenterol 2024; 30(23): 2959-2963 [DOI: 10.3748/wjg.v30.i23.2959]
Corresponding Author of This Article
Hui Wang, MD, Department of Oncology, Zhejiang Xiaoshan Hospital, No. 728 Yucai North Road, Xiaoshan District, Hangzhou 310018, China. wanghui19840106@126.com
Research Domain of This Article
Biology
Article-Type of This Article
Editorial
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Ying Wang, Zheng-Long Wu, Yi-Gang Wang, Xiao-Yuan Jia, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou 310018, Zhejiang Province, China
Ying Wang, Hui Wang, Department of Oncology, Zhejiang Xiaoshan Hospital, Hangzhou 310018, Zhejiang Province, China
Co-corresponding authors: Yi-Gang Wang and Hui Wang.
Author contributions: Wang Y performed the majority of the writing; Wu ZL and Wang H coordinated the writing of the paper; Jia XY and Wang YG contributed to the conception and design of the paper, literature review, critical revision and approval of the final version.
Supported byThe Hangzhou Medical Health Science and Technology Project, No. B20220173; The Public Welfare Technology Project of Zhejiang Province, No. LGF21H160033; and Zhejiang Medical Technology Plan Project, No. 2021KY047.
Conflict-of-interest statement: Dr. Wang has nothing to disclose.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Hui Wang, MD, Department of Oncology, Zhejiang Xiaoshan Hospital, No. 728 Yucai North Road, Xiaoshan District, Hangzhou 310018, China. wanghui19840106@126.com
Received: March 22, 2024 Revised: May 15, 2024 Accepted: May 27, 2024 Published online: June 21, 2024 Processing time: 90 Days and 23.3 Hours
Abstract
In this editorial, we comment on the article entitled “Stage at diagnosis of colorectal cancer through diagnostic route: Who should be screened?” by Agatsuma et al. Colorectal cancer (CRC) is emerging as an important health issue as its incidence continues to rise globally, adversely affecting the quality of life. Although the public has become more aware of CRC prevention, most patients lack screening awareness. Some poor lifestyle practices can lead to CRC and symptoms can appear in the early stages of CRC. However, due to the lack of awareness of the disease, most of the CRC patients are diagnosed already at an advanced stage and have a poor prognosis.
Core Tip: Briefly summarises the factors that contribute to colorectal cancer (CRC) and the early symptoms. The use of the immunochemical fecal occult blood test in different countries is explored as well as the importance of screening at an early stage. Highlighting the critical role of early screening in CRC treatment, this editorial carefully blends social context and scientific insights to reveal the dynamic landscape of this evolving field.
